Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Eligard 6-month on disease biomarkers in metastatic prostate cancer
2012-000101-69Phase 4Terminated
- Sponsor
- Astellas Pharma
- Start
- Jul 2013
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of leuprolide in prostate cancer (PCa), sponsored by Astellas Pharma. Started Jul 2013; status: terminated.
02
Drugs
leuprolide
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on 2012-000101-69.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000101-69.